AKT1 and ovarian carcinoma: Delphinidin prominently inhibits the brain-derived neurotrophic factor (BDNF)-induced increase in cell migration and invasion of SKOV3 ovarian cancer cells by decreasing the expression of MMP-2, MMP-9, and AKT pathways (96) and also inhibits proliferation by participating in the PI3K/AKT and ERK1/2 MAPK signaling cascades (97).